SCHEMBL17126983

SCHEMBL17126983

CCOCCSC(C(=O)c1ccc(Oc2c(OC)cc(OC)cc2OC)cc1)C(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TUBB1 Q9H4B7 2/20 0.35
▸ TUBB4A P04350 1/20 0.35
▸ TUBB P07437 1/20 0.35
▸ TUBA3C P0DPH7 1/20 0.35
▸ TUBA1B P68363 1/20 0.35
▸ TUBA4A P68366 1/20 0.35
▸ TUBB4B P68371 1/20 0.35
▸ TUBB3 Q13509 1/20 0.35
▸ TUBB2A Q13885 1/20 0.35
▸ TUBB8 Q3ZCM7 1/20 0.35
▸ TUBA3E Q6PEY2 1/20 0.35
▸ TUBA1A Q71U36 1/20 0.35
▸ TUBA1C Q9BQE3 1/20 0.35
▸ TUBB6 Q9BUF5 1/20 0.35
▸ TUBB2B Q9BVA1 1/20 0.35
▸ SLC2A1 P11166 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17126975 0.90 TTR (0.39) SMN1; SMN2HPGDALDH1A1LMNAMAPT
SCHEMBL17126973 0.88 SMN1; SMN2 (0.43) SMN1; SMN2HPGDSLC2A1ALDH1A1LMNA
SCHEMBL17127021 0.88 KDM4E (0.34) SMN1; SMN2HPGDSLC2A1ALDH1A1LMNA
SCHEMBL15935680 0.87 SMN1; SMN2 (0.46) SMN1; SMN2HPGDSLC2A1ALDH1A1LMNA
SCHEMBL17126862 0.85 AKR1C3 (0.39) SMN1; SMN2HPGDSLC2A1ALDH1A1LMNA
SCHEMBL17126864 0.85 SCN9A (0.33) SMN1; SMN2HPGDLMNAMAPTKDM4E
SCHEMBL17127023 0.82 KDM4E (0.37) SMN1; SMN2ALDH1A1LMNAMAPTHTT
SCHEMBL17126976 0.82 PPARA (0.40) SMN1; SMN2HPGDALDH1A1NPC1
SCHEMBL17127019 0.82 LMNA (0.41) SMN1; SMN2HPGDSLC2A1ALDH1A1LMNA
SCHEMBL17127022 0.79 PTGS2 (0.38) SMN1; SMN2ALDH1A1LMNAKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS SMN1; SMN2 2675/4885HPGD 2453/4885TUBB1 808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback